Veracity Capital LLC Acquires 31,494 Shares of Avantor, Inc. (NYSE:AVTR)

Veracity Capital LLC grew its holdings in shares of Avantor, Inc. (NYSE:AVTR - Free Report) by 63.2% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 81,309 shares of the company's stock after purchasing an additional 31,494 shares during the period. Veracity Capital LLC's holdings in Avantor were worth $1,318,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in AVTR. Smartleaf Asset Management LLC boosted its holdings in Avantor by 106.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,611 shares of the company's stock valued at $34,000 after purchasing an additional 830 shares in the last quarter. Global Retirement Partners LLC lifted its position in shares of Avantor by 76.7% during the 4th quarter. Global Retirement Partners LLC now owns 2,459 shares of the company's stock worth $52,000 after buying an additional 1,067 shares during the last quarter. AlphaQuest LLC acquired a new position in shares of Avantor in the 4th quarter valued at $65,000. Signaturefd LLC grew its position in shares of Avantor by 24.9% in the 4th quarter. Signaturefd LLC now owns 4,566 shares of the company's stock valued at $96,000 after buying an additional 911 shares during the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in Avantor by 10.5% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 6,257 shares of the company's stock worth $132,000 after acquiring an additional 592 shares in the last quarter. 95.08% of the stock is currently owned by institutional investors and hedge funds.

Avantor Stock Performance

Shares of AVTR stock traded down $0.36 on Thursday, hitting $12.95. 9,303,868 shares of the stock traded hands, compared to its average volume of 8,074,438. The company's fifty day moving average is $13.89 and its 200 day moving average is $17.79. Avantor, Inc. has a 1-year low of $11.82 and a 1-year high of $28.00. The company has a market capitalization of $8.82 billion, a PE ratio of 12.45, a PEG ratio of 1.55 and a beta of 1.09. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.07 and a quick ratio of 0.70.

Avantor (NYSE:AVTR - Get Free Report) last released its quarterly earnings results on Friday, April 25th. The company reported $0.23 EPS for the quarter, hitting the consensus estimate of $0.23. The business had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.61 billion. Avantor had a net margin of 10.49% and a return on equity of 12.17%. The company's quarterly revenue was down 5.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.22 earnings per share. On average, equities research analysts predict that Avantor, Inc. will post 1.06 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, Director Joseph R. Massaro bought 8,100 shares of the business's stock in a transaction on Tuesday, April 29th. The shares were bought at an average cost of $12.30 per share, with a total value of $99,630.00. Following the purchase, the director now directly owns 35,038 shares in the company, valued at $430,967.40. This trade represents a 30.07% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Gregory L. Summe acquired 25,000 shares of Avantor stock in a transaction that occurred on Wednesday, May 7th. The stock was acquired at an average cost of $12.00 per share, with a total value of $300,000.00. Following the completion of the purchase, the director now owns 50,000 shares in the company, valued at approximately $600,000. This represents a 100.00% increase in their position. The disclosure for this purchase can be found here. Insiders acquired 83,100 shares of company stock valued at $1,027,630 in the last three months. 1.20% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on AVTR. Citigroup decreased their target price on Avantor from $22.00 to $18.00 and set a "neutral" rating for the company in a research report on Tuesday, March 4th. Royal Bank of Canada lowered their target price on shares of Avantor from $24.00 to $20.00 and set an "outperform" rating on the stock in a research report on Monday, April 28th. Barclays cut their target price on shares of Avantor from $18.00 to $15.00 and set an "overweight" rating on the stock in a report on Monday, April 28th. Robert W. Baird decreased their price target on shares of Avantor from $21.00 to $17.00 and set an "outperform" rating for the company in a research note on Monday, April 28th. Finally, Cowen lowered shares of Avantor from a "buy" rating to a "hold" rating in a research note on Monday, April 28th. Seven analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat.com, Avantor presently has a consensus rating of "Hold" and an average target price of $18.88.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.